Proton

The Green Hydrogen Market Opportunities Explode, Igniting Tremendous Growth From $6 Billion in 2023 to $84 Billion by 2029- Arizton

Retrieved on: 
Tuesday, January 16, 2024

The feasibility of green hydrogen production is currently contingent on the development of demand and the global market growth, both of which remain relatively limited.

Key Points: 
  • The feasibility of green hydrogen production is currently contingent on the development of demand and the global market growth, both of which remain relatively limited.
  • The widespread adoption of green hydrogen can stimulate competitive value chains and create new investment opportunities for nations trying to position themselves in this burgeoning industry.
  • Despite being in its early stages, the global market for green hydrogen holds significant potential in the energy transition scenario.
  • The green hydrogen market has been gaining significant attention and undergoing dynamic changes.

Polestar announces Board and Management appointments

Retrieved on: 
Thursday, January 11, 2024

Polestar Automotive Holding UK PLC (Nasdaq: PSNY), the Swedish electric performance car brand, announces appointments to its Board of Directors and Management Team.

Key Points: 
  • Polestar Automotive Holding UK PLC (Nasdaq: PSNY), the Swedish electric performance car brand, announces appointments to its Board of Directors and Management Team.
  • View the full release here: https://www.businesswire.com/news/home/20240111729731/en/
    Winfried Vahland has been appointed to the Board as a new director.
  • Winfried was previously CEO and President of Volkswagen Group China, Chairman of the Executive Board of Skoda Auto and a Member of the Board of Volvo Cars.
  • Håkan Samuelsson, Chairman of Polestar’s Board of Directors, says: “I’m delighted to welcome Winfried to the Board.

Global Fuel Cell Market Forecast Report 2023-2028: Increasing Generation of Distributed Power Using Low-Carbon Fuels

Retrieved on: 
Thursday, January 11, 2024

Additionally, the fuel cell market will grow in the future owing to the increased requirement for fuel cell setup in power generation and combined heat and power (CHP) applications.

Key Points: 
  • Additionally, the fuel cell market will grow in the future owing to the increased requirement for fuel cell setup in power generation and combined heat and power (CHP) applications.
  • Proton exchange membrane fuel cell: The second largest segment of the fuel cell market, by type
    Based on type, the fuel cell market has been split into two types: solid oxide fuel cell, proton exchange membrane fuel cell, phosphoric acid fuel cell, microbial fuel cell, direct methanol fuel cell, and alkaline fuel cell.
  • Based on application, the fuel cell market is segmented into stationary, fuel cell vehicles, and portable.
  • The fuel cell vehicles segment is expected to be the second-largest segment of the fuel cell market during the forecast period.

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Retrieved on: 
Wednesday, January 10, 2024

In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.

Key Points: 
  • In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.
  • This makes it possible to better delineate the tumour from the surrounding healthy tissue and to more precisely define the volume to be irradiated.
  • The prototype, based on the ASG technology already used for the MROpenEVO system, the only MRI in the world with a completely open design and MgB2 cryogen-free superconductive technology, will be used to demonstrate through scientific studies the added value of this new treatment modality for tumours in the chest, abdomen and pelvis.
  • Marco Nassi, CEO – ASG Superconductors declared "It is very challenging to contribute to such an innovative technical and scientific project in the proton therapy sector in close collaboration with highly prestigious hospitals, partners, and universities.

More accurate tumour treatment thanks to superconductive ASG Superconductors technology

Retrieved on: 
Wednesday, January 10, 2024

In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.

Key Points: 
  • In fact, MRI offers the advantage over conventional imaging modalities of being able to visualise tumours with unsurpassed soft tissue image contrast.
  • This makes it possible to better delineate the tumour from the surrounding healthy tissue and to more precisely define the volume to be irradiated.
  • The prototype, based on the ASG technology already used for the MROpenEVO system, the only MRI in the world with a completely open design and MgB2 cryogen-free superconductive technology, will be used to demonstrate through scientific studies the added value of this new treatment modality for tumours in the chest, abdomen and pelvis.
  • Marco Nassi, CEO – ASG Superconductors declared "It is very challenging to contribute to such an innovative technical and scientific project in the proton therapy sector in close collaboration with highly prestigious hospitals, partners, and universities.

HyAxiom Showcases Revolutionary Green Hydrogen Solutions at CES 2024 for the First Time

Retrieved on: 
Tuesday, January 9, 2024

LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- HyAxiom, Inc., the leader in green hydrogen solutions, which are driving a "carbon-free future, today," is showcasing its products at CES 2024 in Doosan Group's Booth 5941, West Hall, in the Las Vegas Convention Center, January 9-12.

Key Points: 
  • LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- HyAxiom, Inc., the leader in green hydrogen solutions, which are driving a "carbon-free future, today," is showcasing its products at CES 2024 in Doosan Group's Booth 5941, West Hall, in the Las Vegas Convention Center, January 9-12.
  • This innovative system facilitates the generation of hydrogen through an electrolysis process, where clean electricity splits water into hydrogen and oxygen.
  • HyAxiom is also exhibiting the PureCell® Model 400, the only commercially available fuel cell which successfully operates on 100% hydrogen.
  • For more information on Doosan's CES 2024 presence, please visit www.doosan.com/en/media-center/ces2024/ or contact [email protected] .

Advent Technologies Secures Funding from Danish Energy Technology Development and Demonstration Program for Innovative R&D Project

Retrieved on: 
Monday, January 8, 2024

Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, is delighted to announce that its subsidiary, Advent Technologies, A/S, has secured funding approval for its latest research and development project from the Danish Energy Technology Development and Demonstration Program (“EUDP”).

Key Points: 
  • Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, is delighted to announce that its subsidiary, Advent Technologies, A/S, has secured funding approval for its latest research and development project from the Danish Energy Technology Development and Demonstration Program (“EUDP”).
  • Advent's next-generation HT-PEM fuel cell applications are built on the groundbreaking Ion-Pair™ Membrane Electrode Assembly (“MEA”) technology.
  • Manufacturing of these fuel cell systems will take place in Kozani, Greece, as part of the EU-approved Green HiPo IPCEI Project.
  • Collectively, we strive for the successful completion of this project, taking us a step closer to a future where HT-PEM fuel cell technology sets the standard in fuel cell usage.”

Hyundai Motor and Kia to Develop Polymer Electrolyte Membrane with Gore for Hydrogen Fuel Cell Systems

Retrieved on: 
Thursday, January 4, 2024

Partnership aims to develop advanced fuel cell system for commercial vehicles, increasing durability and performance

Key Points: 
  • Partnership aims to develop advanced fuel cell system for commercial vehicles, increasing durability and performance
    SEOUL, South Korea, Jan. 4, 2024 /PRNewswire/ -- Hyundai Motor Company (Hyundai Motor), Kia Corporation (Kia) and W. L. Gore & Associates (Gore) have signed an agreement at the Mabuk Eco-Friendly R&D Center, Korea, to collaborate on the development of advanced polymer electrolyte membrane (PEM) for hydrogen fuel cell systems.
  • The ultimate goal of this collaboration is to develop an advanced PEM for next-generation fuel cell electric commercial vehicles.
  • For over 15 years, Hyundai Motor, Kia and Gore have been collaborating in the field of fuel cells.
  • Combining Gore's pioneering PEM technology with Hyundai Motor and Kia's advanced fuel cell expertise, Hyundai Motor and Kia aims to incorporate advanced PEM technology into next-generation fuel cell systems for passenger cars, commercial vehicles and non-automotive sectors.

Hyundai Motor and Kia to Develop Polymer Electrolyte Membrane with Gore for Hydrogen Fuel Cell Systems

Retrieved on: 
Thursday, January 4, 2024

Partnership aims to develop advanced fuel cell system for commercial vehicles, increasing durability and performance

Key Points: 
  • Partnership aims to develop advanced fuel cell system for commercial vehicles, increasing durability and performance
    SEOUL, South Korea, Jan. 4, 2024 /PRNewswire/ -- Hyundai Motor Company (Hyundai Motor), Kia Corporation (Kia) and W. L. Gore & Associates (Gore) have signed an agreement at the Mabuk Eco-Friendly R&D Center, Korea, to collaborate on the development of advanced polymer electrolyte membrane (PEM) for hydrogen fuel cell systems.
  • The ultimate goal of this collaboration is to develop an advanced PEM for next-generation fuel cell electric commercial vehicles.
  • For over 15 years, Hyundai Motor, Kia and Gore have been collaborating in the field of fuel cells.
  • Combining Gore's pioneering PEM technology with Hyundai Motor and Kia's advanced fuel cell expertise, Hyundai Motor and Kia aims to incorporate advanced PEM technology into next-generation fuel cell systems for passenger cars, commercial vehicles and non-automotive sectors.

Radiation therapy takes advantage of cancer's poor DNA repair abilities – an oncologist and physicist explain how

Retrieved on: 
Wednesday, January 3, 2024

Ionizing radiation, or the emission of high-energy waves or particles, works as a therapy by damaging a cancer cell’s DNA.

Key Points: 
  • Ionizing radiation, or the emission of high-energy waves or particles, works as a therapy by damaging a cancer cell’s DNA.
  • It’s an effective tool for killing cancer cells because they are generally much less adept at DNA repair compared to healthy cells.
  • Damaging specific parts of DNA prevents cancer cells from reproducing, effectively killing them.

Fundamentals of radiation therapy

  • At the heart of radiation therapy lies the fundamental principle that cancer cells are more susceptible to radiation than healthy cells.
  • Sometimes resistance to radiation in cancer cells may be comparable or even greater than that of their neighboring cells.
  • When tumors lie close to vital organs that are highly sensitive to radiation, such as the brain or the bowels, it significantly limits the amount of radiation that can be delivered.

External beam radiation therapy

  • External beam radiation involves directing radiation from an outside source to a single part of the body.
  • Another form of radiotherapy is proton beam therapy, or PBT, which directs protons instead of X-rays at tumors.

Image-guided radiation therapy

  • By acting as the eyes of the care team, imaging reduced uncertainty about the location of tumors and improved the precision and accuracy of radiation therapy.
  • Newer linear accelerators are now incorporating MRIs, which significantly improve visualization of patient anatomy and tumors, further advancing treatment precision and accuracy.


Researchers are also adding positron emission tomography, or PET, scanners that provide information about the metabolic function of tumors. This advance makes it possible to increase the radiation dose specifically at the most active areas of tumors.

Adaptive therapy

  • An emerging approach to radiation therapy called adaptive therapy uses imaging to dynamically adjust treatment as the tumor or its positioning changes each day.
  • However, adaptive therapy may apply several adjustments or lead to a completely new treatment plan in order to address changes to the tumor’s condition over the course of treatment.
  • The fact that the process needs to be repeated multiple times renders adaptive therapy particularly resource-intensive and time-consuming.

Brachytherapy

  • Brachytherapy – stemming from the Greek word “brachys,” meaning “short” – is another widely used method in radiation therapy.
  • In contrast to external beam radiation therapy, where radiation often must pass through healthy tissue to reach cancer cells, brachytherapy applies radiation directly to the tumor.
  • The conventional approach to brachytherapy involved using needles to place or inject radioactive seeds inside or adjacent to the cancerous tissue.
  • An increasingly popular form of brachytherapy called high-dose rate brachytherapy involves using a tube to guide a more highly radioactive seed directly to the affected tissue before removing it after a few minutes.

Future of radiation therapy

  • Researchers are also exploring treatments using ions heavier than protons to more effectively damage DNA in cancer cells and enhance the efficacy of radiation therapy.
  • Advances in the field hint at a future of more personalized radiation therapy, highlighting the fusion of technology and medical expertise in the fight against cancer.


The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their academic appointment.